<VariationArchive VariationID="221278" VariationName="NM_004656.4(BAP1):c.1717del (p.Leu573fs)" VariationType="Deletion" Accession="VCV000221278" Version="26" RecordType="classified" NumberOfSubmissions="12" NumberOfSubmitters="11" DateLastUpdated="2024-07-29" DateCreated="2016-02-09" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="222989" VariationID="221278">
      <GeneList>
        <Gene Symbol="BAP1" FullName="BRCA1 associated deubiquitinase 1" GeneID="8314" HGNC_ID="HGNC:950" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="52401008" stop="52410008" display_start="52401008" display_stop="52410008" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="52435023" stop="52444008" display_start="52435023" display_stop="52444008" Strand="-" />
          </Location>
          <OMIM>603089</OMIM>
          <Haploinsufficiency last_evaluated="2019-12-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BAP1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-12-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BAP1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004656.4(BAP1):c.1717del (p.Leu573fs)</Name>
      <CanonicalSPDI>NC_000003.12:52403427:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="52403428" stop="52403428" display_start="52403428" display_stop="52403428" variantLength="1" positionVCF="52403427" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="52437444" stop="52437444" display_start="52437444" display_stop="52437444" variantLength="1" positionVCF="52437443" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>L573fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.52437447del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.52437447del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.52403431del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.52403431del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031859.1" sequenceAccession="NG_031859" sequenceVersion="1" change="g.11566del">
            <Expression>NG_031859.1:g.11566del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004656.4" sequenceAccession="NM_004656" sequenceVersion="4" change="c.1717del" MANESelect="true">
            <Expression>NM_004656.4:c.1717del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004647.1" sequenceAccession="NP_004647" sequenceVersion="1" change="p.Leu573fs">
            <Expression>NP_004647.1:p.Leu573fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_529" sequenceAccession="LRG_529">
            <Expression>LRG_529:g.11566del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_529t1" sequenceAccession="LRG_529t1">
            <Expression>LRG_529t1:c.1717del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA351499" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="603089.0005" DB="OMIM" />
        <XRef Type="Allelic variant" ID="603089.0015" DB="OMIM" />
        <XRef Type="rs" ID="869025212" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="protein truncation">
        <XRef ID="0015" DB="Variation Ontology" />
        <Comment DataSource="Thoracic Oncology, University of Hawaii Cancer Center" Type="public">Variant leads to a truncated protein lacking the nuclear localization signal. Variant functional consequence was validated by IHC showing lack of BAP1 nuclear staining in tumor cells carrying LOH (LOH was confirmed by sequencing). It is already established that BAP1 nuclear localization is required for its the tumor suppressor functions.</Comment>
      </FunctionalConsequence>
      <FunctionalConsequence Value="effect on protein subcellular localization">
        <XRef ID="0033" DB="Variation Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004656.4(BAP1):c.1717del (p.Leu573fs) AND BAP1 Cancer Syndrome" Accession="RCV000207031" Version="9">
        <ClassifiedConditionList TraitSetID="23757">
          <ClassifiedCondition DB="MedGen" ID="CN235077">BAP1 Cancer Syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004656.4(BAP1):c.1717del (p.Leu573fs) AND BAP1-related tumor predisposition syndrome" Accession="RCV000464745" Version="21">
        <ClassifiedConditionList TraitSetID="7637">
          <ClassifiedCondition DB="MedGen" ID="C3280492">BAP1-related tumor predisposition syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-20" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004656.4(BAP1):c.1717del (p.Leu573fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV000567996" Version="16">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-05-10" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004656.4(BAP1):c.1717del (p.Leu573fs) AND not provided" Accession="RCV001795342" Version="14">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-04" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004656.4(BAP1):c.1717del (p.Leu573fs) AND Melanoma, uveal, susceptibility to, 2" Accession="RCV002273820" Version="8">
        <ClassifiedConditionList TraitSetID="79243">
          <ClassifiedCondition DB="MedGen" ID="C1847723">Melanoma, uveal, susceptibility to, 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-08-04" SubmissionCount="1">risk factor</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-20" NumberOfSubmissions="12" NumberOfSubmitters="11" DateCreated="2016-02-09" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21874000</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23684012</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25687217</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26556299</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26683624</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26719535</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28793149</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32002398</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7637" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16619" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">COMMON Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition syndrome</ElementValue>
                <XRef ID="TUMOR+PREDISPOSITION+SYNDROME/9432" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor susceptibility linked to germline BAP1 mutations</ElementValue>
                <XRef ID="289539" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">BAP1-related tumor predisposition syndrome</ElementValue>
                <XRef ID="MONDO:0013692" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TUMOR PREDISPOSITION SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="614327" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BAP1 tumor predisposition syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TPDS1</ElementValue>
                <XRef Type="MIM" ID="614327" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">TPDS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13219" />
                <XRef ID="13219" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">BAP1 tumor predisposition syndrome (BAP1-TPDS) is associated with an increased risk for a specific skin lesion, BAP1-inactivated melanocytic tumors (BIMT; formerly called atypical Spitz tumors), and the following cancers, in descending order of frequency: uveal (eye) melanoma (UM), malignant mesothelioma (MMe), cutaneous melanoma (CM), renal cell carcinoma (RCC), and basal cell carcinoma (BCC). Hepatocellular carcinoma, cholangiocarcinoma, and meningioma may also be associated with BAP1-TPDS. Affected individuals can have more than one type of primary cancer. In general, the median age of onset of these tumors is younger than in the general population. UM tends to be a more aggressive class 2 tumor with higher risk for metastasis and reduced survival compared to UM occurring in the general population. Due to the limited number of families reported to date, the penetrance, natural history, and frequencies of BAP1-associated tumors are yet to be determined. Other suspected but unconfirmed tumors in BAP1-TPDS include (in alphabetic order): breast cancer, neuroendocrine carcinoma, non-small-cell lung adenocarcinoma, thyroid cancer, and urinary bladder cancer.</Attribute>
                <XRef ID="NBK390611" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27748099</ID>
                <ID Source="BookShelf">NBK390611</ID>
              </Citation>
              <XRef ID="289539" DB="Orphanet" />
              <XRef ID="C3280492" DB="MedGen" />
              <XRef ID="MONDO:0013692" DB="MONDO" />
              <XRef Type="MIM" ID="614327" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="23757" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34567" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">BAP1 Cancer Syndrome</ElementValue>
                <XRef ID="c.1717delC, p.L573fs*3" DB="Thoracic Oncology, University of Hawaii Cancer Center" />
              </Name>
              <XRef ID="CN235077" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="79243" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2881" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Melanoma, uveal, susceptibility to, 2</ElementValue>
                <XRef ID="MONDO:0011696" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Melanoma, uveal 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">UVM2</ElementValue>
                <XRef Type="MIM" ID="606661" DB="OMIM" />
              </Symbol>
              <Citation Type="Suggested Reading" Abbrev="Papastefanou et al., 2011">
                <ID Source="pmc">3135138</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/uveal.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesÂ®) Melanoma: Uveal, 2023</CitationText>
              </Citation>
              <XRef ID="39044" DB="Orphanet" />
              <XRef ID="C1847723" DB="MedGen" />
              <XRef ID="MONDO:0011696" DB="MONDO" />
              <XRef Type="MIM" ID="606661" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="491048" SubmissionDate="2015-10-20" DateLastUpdated="2016-02-09" DateCreated="2016-02-09">
        <ClinVarSubmissionID localKey="c.1717delC, p.L573fs*3|BAP1 Cancer Syndrome" />
        <ClinVarAccession Accession="SCV000256058" DateUpdated="2016-02-09" DateCreated="2016-02-09" Type="SCV" Version="1" SubmitterName="Thoracic Oncology, University of Hawaii Cancer Center" OrgID="505574" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-10-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25687217</ID>
          </Citation>
          <Comment>We found 100% penetrance of at least one cancer type in every individual carrying this variant. Our results indicate that this variant has a high prognostic significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Carbone et al. (PLoS Genet 2015)</Attribute>
          <Citation>
            <ID Source="PubMed">26683624</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Caucasian</Ethnicity>
              <GeographicOrigin>Europe</GeographicOrigin>
              <Tissue>blood and tumor tissues</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">50</Age>
              <Age Type="maximum" age_unit="years">80</Age>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>41</NumberTested>
              <Gender>mixed</Gender>
              <FamilyData NumFamilies="37" NumFamiliesWithSegregationObserved="4" NumFamiliesWithVariant="4">
                <FamilyHistory>yes</FamilyHistory>
              </FamilyData>
            </Sample>
            <Method>
              <Purpose>assert pathogenicity</Purpose>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="6" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="6" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="6" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">malignant mesothelioma</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">uveal melanoma</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">renal cell carcinoma</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">basal cell carcinoma</ElementValue>
                </Name>
              </Trait>
            </TraitSet>
            <Citation>
              <ID Source="PubMed">25687217</ID>
            </Citation>
            <Comment>Number of families with variant: There are 4 apparently unrelated families, however we have performed extensive genealogy search and found that these 4 families share a common ancestor nine generation above the probands. Number of homozygotes: Homozygous variants of BAP1gene which generate loss of protein function are lethal</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BAP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_004656.3:exon13</GeneLocation>
          </Location>
          <FunctionalConsequence Value="protein truncation">
            <XRef DB="Variation Ontology" ID="0015" URL="http://www.variationontology.org/cgi-bin/amivario/term-details.cgi?term=VariO:0015" />
            <Comment>Variant leads to a truncated protein lacking the nuclear localization signal. Variant functional consequence was validated by IHC showing lack of BAP1 nuclear staining in tumor cells carrying LOH (LOH was confirmed by sequencing). It is already established that BAP1 nuclear localization is required for its the tumor suppressor functions.</Comment>
          </FunctionalConsequence>
          <FunctionalConsequence Value="effect on protein subcellular localization">
            <XRef DB="Variation Ontology" ID="0033" URL="http://www.variationontology.org/cgi-bin/amivario/term-details.cgi?term=VariO:0033" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004656.3:c.1717delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">BAP1 Cancer Syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">26683624</ID>
        </Citation>
      </ClinicalAssertion>
      <ClinicalAssertion ID="49785" SubmissionDate="2019-10-10" DateLastUpdated="2022-08-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603089.0005_TUMOR PREDISPOSITION SYNDROME 1" title="BAP1, 1-BP DEL, 1832C_TUMOR PREDISPOSITION SYNDROME 1" />
        <ClinVarAccession Accession="SCV000044529" DateUpdated="2022-08-08" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-08-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with tumor predisposition syndrome-1 (TPDS1; 614327) who developed malignant mesothelioma and a uveal melanoma, Testa et al. (2011) identified a heterozygous germline 1-bp deletion (1832delC) in exon 13 of the BAP1 gene, resulting in a frameshift and truncation upstream of the BAP1 nuclear localization signal.</Attribute>
              <Citation>
                <ID Source="PubMed">21874000</ID>
              </Citation>
              <XRef DB="OMIM" ID="614327" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BAP1" />
          </GeneList>
          <Name>BAP1, 1-BP DEL, 1832C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1832C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603089.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TUMOR PREDISPOSITION SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1359154" SubmissionDate="2017-11-15" DateLastUpdated="2022-12-11" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="11_October 2017|OMIM:614327" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000693457" DateUpdated="2022-12-11" DateCreated="2017-12-26" Type="SCV" Version="2" SubmitterName="Center of Genomic medicine, Geneva, University Hospital of Geneva" OrgID="505593" OrganizationCategory="laboratory" OrgAbbreviation="GenMed_GVA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This mutation (deletion of one nucleotide in the BAP1 gene) was identified in a male patient with familial history of melanoma and mesothelioma</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">50</Age>
              <Age Type="maximum" age_unit="years">59</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BAP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.(Leu573Trpfs*3)</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004656.3:c.1717del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614327" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Genome_Clinic_of_Geneva_November2017</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1338132" SubmissionDate="2024-01-25" DateLastUpdated="2024-02-14" DateCreated="2018-02-19">
        <ClinVarSubmissionID localKey="Db4KrQBSZeoE7-orUyypkb2fYJfv4TZ57lyoUUh6uvQ|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000682589" DateUpdated="2024-02-14" DateCreated="2018-02-19" Type="SCV" Version="4" SubmitterName="Color Diagnostics, LLC DBA Color Health" OrgID="505849" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant deletes 1 nucleotide in exon 13 of the BAP1 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has been reported in individuals affected with uveal melanoma, malignant mesothelioma, and melanocytic BAP1-mutated atypical intradermal tumors (MBAITs; PMID: 21874000, 25687217, 26683624, 26719535, 28793149). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of BAP1 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BAP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004656.4:c.1717del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Color Genomics - ClinVar Submission - May2020 - SUB747</SubmissionName>
          <SubmissionName>SUB10927044</SubmissionName>
          <SubmissionName>SUB14171678</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1066875" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2017-04-17">
        <ClinVarSubmissionID localKey="786549|MedGen:C3280492" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000553965" DateUpdated="2024-02-20" DateCreated="2017-04-17" Type="SCV" Version="9" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21874000</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23684012</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21874000</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25687217</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26683624</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu573Trpfs*3) in the BAP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BAP1 are known to be pathogenic (PMID: 21874000, 23684012). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with mesothelioma and uveal melanoma (PMID: 21874000, 25687217, 26683624). This variant is also known as 1832delC. ClinVar contains an entry for this variant (Variation ID: 221278). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BAP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.52437444del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3280492" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1300001" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2018-01-01">
        <ClinVarSubmissionID localKey="a75891|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000664583" DateUpdated="2024-05-01" DateCreated="2018-01-01" Type="SCV" Version="5" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21874000</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25687217</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26556299</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26683624</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26719535</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28793149</ID>
          </Citation>
          <Comment>The c.1717delC pathogenic mutation, located in coding exon 13 of the BAP1 gene, results from a deletion of one nucleotide at nucleotide position 1717, causing a translational frameshift with a predicted alternate stop codon (p.L573Wfs*3). This mutation has been reported in multiple kindreds with malignant mesothelioma, uveal melanoma, and/or other BAP-1 associated cancers (Cebulla CM et al. Ophthalmic Genet. 2015 Jun;36:126-31; Ohar JA et al. Cancer Res. 2016 Jan;76:206-15; Testa JR et al. Nat. Genet. 2011 Oct;43:1022-5; Carbone M et al. PLoS Genet. 2015 Dec;11:e1005633; Schrader KA et al. JAMA Oncol. 2016 Jan;2:104-11; Haugh AM et al. JAMA Dermatol. 2017 Oct;153:999-1006; Hassan R et al. Proc Natl Acad Sci U S A 2019 04;116(18):9008-9013). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BAP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004656.2:c.1717delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1570104" SubmissionDate="2018-06-26" DateLastUpdated="2018-02-19" DateCreated="2018-02-19">
        <ClinVarSubmissionID localKey="NM_004656.3:c.1717delC|Hereditary cancer-predisposing syndrome" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000805223" DateUpdated="2018-02-19" DateCreated="2018-02-19" Type="SCV" Version="1" SubmitterName="True Health Diagnostics" OrgID="506273" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-06-05">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BAP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004656.3:c.1717delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4205407</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4052667" SubmissionDate="2022-01-25" DateLastUpdated="2022-01-29" DateCreated="2022-01-29">
        <ClinVarSubmissionID localKey="NM_004656.3(BAP1):c.1717del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002066588" DateUpdated="2022-01-29" DateCreated="2022-01-29" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>DNA sequence analysis of the BAP1 gene demonstrated a single base pair deletion in exon 13, c.1717del. This pathogenic sequence change results in an amino acid frameshift and creates a premature stop codon three amino acids downstream of the change, p.Leu573Trpfs*3. This pathogenic sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated BAP1 protein with potentially abnormal function. The c.1717del sequence change has not been described in population databases such as ExAC and gnomAD. This pathogenic sequence change has previously been described in individual with BAP1-related tumors and cancers (PMID: 32002398, 26719535, 31206729, 28793149, 26683624, 21874000, 25687217). Collectively, these evidences indicated this sequence change is pathogenic, however functional studies have not been performed to prove this conclusively.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BAP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004656.3:c.1717del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10987855</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5006572" SubmissionDate="2022-08-04" DateLastUpdated="2022-08-08" DateCreated="2022-08-08">
        <ClinVarSubmissionID localKey="603089.0015_MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2" title="BAP1, 1-BP DEL, 1717C_MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2" />
        <ClinVarAccession Accession="SCV002558798" DateUpdated="2022-08-08" DateCreated="2022-08-08" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>risk factor</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Tumor Predisposition Syndrome 1</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 6 affected members of a large kindred (K4) of European origin with tumor predisposition syndrome-1 (TPDS1; 614327), Carbone et al. (2015) identified a heterozygous germline 1-bp deletion (c.1717delC) in exon 13 of the BAP1 gene, resulting in a frameshift and premature termination (Leu573fsTer3). The mutation, which was found by exome sequencing and confirmed, segregated with the disorder in the family in those who were genotyped. The mutant protein was predicted to lack the nuclear localization signal, and immunohistochemical studies of mesothelioma tissue showed lack of nuclear BAP1 staining with only cytoplasmic localization. Somatic loss of heterozygosity of the BAP1 gene was confirmed in available tumor tissue. These findings were consistent with BAP1 being a tumor suppressor gene. Multiple family members spanning at least 6 generations showed various types of cancer, including malignant mesothelioma, uveal melanoma, basal cell carcinoma, leiomyosarcoma, renal cell carcinoma, and cutaneous melanoma. One mutation carrier had breast cancer. There was high penetrance of cancer manifestation by age 55 years. Carbone et al. (2015) emphasized the importance of identifying mutation carriers in this family who can then be monitored for malignant mesothelioma or other cancers, because early detection and diagnosis can lead to effective treatment.</Attribute>
              <Citation>
                <ID Source="PubMed">26683624</ID>
              </Citation>
              <XRef DB="OMIM" ID="614327" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Melanoma, Uveal, Susceptibility to, 2</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 48-year-old Caucasian man (patient 1) with bilateral uveal melanoma-2 (UVM2; 606661), Yu et al. (2020) identified a germline heterozygous c.1717delC mutation in the BAP1 gene. Functional studies of the variant were not performed. Cytogenetic profile of tumor tissue showed somatic disomy of chromosomes 3, 6, and 8. Family history was significant for ovarian and bladder cancer in his mother and pancreatic cancer in his maternal great-grandfather, although familial genetic segregation studies were not conducted. The patient did not have other tumors or systemic metastasis.</Attribute>
              <Citation>
                <ID Source="PubMed">32002398</ID>
              </Citation>
              <XRef DB="OMIM" ID="606661" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BAP1" />
          </GeneList>
          <Name>BAP1, 1-BP DEL, 1717C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1717C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603089.0015" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7113108" SubmissionDate="2023-03-02" DateLastUpdated="2023-03-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="102125722|OMIM:614327" />
        <ClinVarAccession Accession="SCV003806652" DateUpdated="2023-03-04" DateCreated="2023-03-04" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BAP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="3" alternateAllele="A" referenceAllele="AG" start="52437443" stop="52437444" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">102125722</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614327" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12928675</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7159475" SubmissionDate="2023-02-19" DateLastUpdated="2023-03-11" DateCreated="2023-03-11">
        <ClinVarSubmissionID localKey="34749|OMIM:614327" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003836027" DateUpdated="2023-03-11" DateCreated="2023-03-11" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004656.4:c.1717del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614327" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12876118</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3988317" SubmissionDate="2023-11-22" DateLastUpdated="2023-11-25" DateCreated="2021-12-18">
        <ClinVarSubmissionID localKey="GDXSV:316270" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002032709" DateUpdated="2023-11-25" DateCreated="2021-12-18" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 32782288, 21874000, 25687217, 26556299, 27813512, 24705312, 28793149, 31206729, 26748926, 26096145, 24855403, 32547381, 26719535, 30883995, 32002398, 26683624, 34628055, 30975761, 37556141, 36513904)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BAP1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:749301</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004656.3:c.1717del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_236_20231122054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_75_20211215054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7113108" TraitType="Disease" MappingType="XRef" MappingValue="614327" MappingRef="OMIM">
        <MedGen CUI="C3280492" Name="BAP1-related tumor predisposition syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="491048" TraitType="Finding" MappingType="Name" MappingValue="renal cell carcinoma" MappingRef="Preferred">
        <MedGen CUI="C0007134" Name="Renal cell carcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5006572" TraitType="Disease" MappingType="Name" MappingValue="MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2" MappingRef="Alternate">
        <MedGen CUI="C1847723" Name="Melanoma, uveal, susceptibility to, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1338132" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="491048" TraitType="Finding" MappingType="Name" MappingValue="uveal melanoma" MappingRef="Preferred">
        <MedGen CUI="C0220633" Name="Uveal melanoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="491048" TraitType="Disease" MappingType="Name" MappingValue="BAP1 Cancer Syndrome" MappingRef="Preferred">
        <MedGen CUI="CN235077" Name="BAP1 Cancer Syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3988317" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4052667" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="49785" TraitType="Disease" MappingType="Name" MappingValue="TUMOR PREDISPOSITION SYNDROME 1" MappingRef="Preferred">
        <MedGen CUI="C3280492" Name="BAP1-related tumor predisposition syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1066875" TraitType="Disease" MappingType="XRef" MappingValue="C3280492" MappingRef="MedGen">
        <MedGen CUI="C3280492" Name="BAP1-related tumor predisposition syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7159475" TraitType="Disease" MappingType="XRef" MappingValue="614327" MappingRef="OMIM">
        <MedGen CUI="C3280492" Name="BAP1-related tumor predisposition syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="491048" TraitType="Finding" MappingType="Name" MappingValue="basal cell carcinoma" MappingRef="Preferred">
        <MedGen CUI="C0007117" Name="Basal cell carcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1570104" TraitType="Disease" MappingType="Name" MappingValue="Hereditary cancer-predisposing syndrome" MappingRef="Preferred">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1359154" TraitType="Disease" MappingType="XRef" MappingValue="614327" MappingRef="OMIM">
        <MedGen CUI="C3280492" Name="BAP1-related tumor predisposition syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="491048" TraitType="Finding" MappingType="Name" MappingValue="malignant mesothelioma" MappingRef="Preferred">
        <MedGen CUI="C0345967" Name="Mesothelioma, malignant" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1300001" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

